-
Compensation Committee
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.'s financial performance into perspective.
Compensation Committee
Compensation Committee
Goran Ando (Chairman)
Rolf Classon
Victor Micati
Charter
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) |  | +0.01 | |
| Volume | 265486 | ||
| 1:20 PM - Mar 09, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
10-30-2007
Enzon Initiates Second Phase 1...
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist
-
05-06-2009
Enzon Reaches Phase II Dose fo...
Enzon Reaches Phase II Dose for PEG-SN38
-- Composition of matter patent granted until 2027-- -
11-29-2007
Enzon to Present at BMO Capita...
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
-
04-23-2008
Cimzia®, Utilizing Enzon's PE...
Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
12-01-2008
Enzon Discontinues its Plan to...
Enzon Discontinues its Plan to Spin-off its Biotechnology Business
-
08-06-2008
Enzon Reports Solid Second Qua...
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% -- -
02-14-2008
Enzon Reports Significant Prog...
Enzon Reports Significant Progress on the Reduction of Its Debt